Calcium Hydroxylapatite Cost
Ingredient: 26mg/ml HA, Hydroxyapatite 30%
Specification: 1ml
Package: Single package
Application Area: Brow bone, temple, nose shaping, apple muscle, decree line, puppet line, chin, etc.
Product Introduction:
In the ever-evolving field of non-surgical facial rejuvenation, Calcium Hydroxylapatite (CaHA) filler stands out as a unique and high-performance solution. Known for its dual-action capabilities—offering both immediate volume and long-term collagen stimulation—CaHA fillers are gaining momentum among aesthetic professionals worldwide. As patient expectations rise for natural, long-lasting results, CaHA-based fillers are quickly becoming a go-to treatment for mid-face contouring, deep wrinkle correction, and skin quality improvement.
Product display:
Product Details:
Type | |
Ingredient | Hyaluronic 26mg/ml, hydroxyapatite 30% |
Specification | 1ml |
Effect area | Subcutaneous injection |
Application area | Brow bone, temple, nose shaping, apple muscle, decree line, puppet line, chin, etc |
How to choose | Moderate to severe naso-lip wrinkles |
Package | Single package |
Storage | Cool, dry environment |
Recommended | 1-2 pc/time |
Recommended interval | 12-24 months |
Lasting time | 18-24 months |
Microsphere size | 25-45μm |
Extruding force | 23N (27G thin-walled needle) |
Product Package:
Customer feedback:
Calcium Hydroxylapatite is a biocompatible substance that closely resembles the mineral component found in human bones and teeth. It has been used safely for years in orthopedics and dentistry. In dermal filler form, CaHA is suspended in a gel carrier made of carboxymethylcellulose. When injected, this gel provides instant volume and lift, while the CaHA microspheres gradually stimulate the body to produce natural collagen over time.
The result? A powerful combination of immediate aesthetic enhancement and biostimulation that improves skin structure, elasticity, and firmness with effects that can last up to 18–24 months.
Development Process:
Company Introduction:
With the aesthetic market shifting toward regenerative and preventative treatments, Calcium Hydroxylapatite is well-positioned for continued growth. Ongoing R&D efforts are focusing on formulation innovations, dual-indication approvals, and combination therapies that pair CaHA with other modalities like microneedling, lasers, or PRP.
In parallel, the rise of minimally invasive procedures and increasing demand from both male and female patients for natural, subtle enhancements are driving global interest in CaHA.
Calcium Hydroxylapatite filler represents a new era in non-surgical aesthetics—one that blends science, structure, and subtlety. With its unique ability to provide immediate volume and long-term collagen regeneration, CaHA stands apart as a trusted, intelligent filler for patients who want more than just temporary results. As innovation continues and access widens, CaHA is not just shaping faces—but shaping the future of aesthetic medicine.





